Health Condition 1: J455- Severe persistent asthma
Conditions
Interventions
Intervention1: Dexamethasone: Intravenous Dexamethasone 0.6 mg/kg single dose, max. dose of 16 mg/day and to be repeated after 24 hours if required and if a child can take it orally, to be given oral
Sponsors
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Children diagnosed with acute severe asthma consistent with severity as per Global Initiative for Asthma Guidelines and Pediatric Asthma Severity Score
Exclusion criteria
Exclusion criteria: I. Patients with cardiovascular, neurological, psychiatric, neoplastic, or renal disease. II. Patients with respiratory conditions like pneumonia, pneumothorax, or pneumomediastinum will be excluded. III. Those children whose parents refused to give consent to participate in the study. IV. Children who have received any systemic steroid preparations in the last 15 days before hospital arrival.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of stay in the emergency department Length of stay in Hospital Need for PICU TransferTimepoint: 6 hours to 48 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Auscultatory findings Frequency of betaagonist Need for respiratory support Any other drug requires like MGSO4 Glucose levelTimepoint: 6 hours, 12 hours, 24 hours, 48 hours | — |
Countries
India
Contacts
Public ContactDr Deepika
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS) Rohtak
Outcome results
None listed